The James Paget Hospital in Great Yarmouth has now become the fifth site in the East of England and the sixth site nationally ...

Effective from 1 October 2025, CMS and commercial health insurers will recognise the HCPCS Level II code A9616 assigned for reimbursement of Gozellix. The assignment of the code is a significant ...

In a bid to better understand how cancer cells power their explosive growth and spread, scientists at Johns Hopkins Medicine ...

Cancer rates are rising among younger people aged under 50. Here’s what we know about the causes – and what the evidence says ...

The most common type of breast cancer in both women and men is called invasive breast cancer - No Special Type (NST). You may also hear it called invasive ductal carcinoma NST. Men can also develop ...

A University of Minnesota Medical School-led research team has discovered that a cancer signaling pathway has previously ...

Some treatments for rheumatoid arthritis could increase cancer risk. One reason is because some cells in our immune system ...

The discovery may explain why cutting edge CAR T-cell therapy has managed to revolutionized treatment for blood cancer but ...

Macrophages are immune cells with a split personality: some fight tumors, while others help them grow. In breast cancer, most ...

One analyst described Cogent’s data as a “home run scenario” for bezuclastinib, which the company is positioning as a ...